Vortioxetine hydrobromide
![]() |
- ₹0
- Product name: Vortioxetine hydrobromide
- CAS: 960203-27-4
- MF: C18H23BrN2S
- MW: 379.36
- EINECS:120-321-1
- MDL Number:MFCD22383961
- Synonyms:Lu AA21004 (HBr);Lu AA 21004 hydrobromide;Vortioxetine hydrobromide;Vortioxetine (Lu AA21004) hydrobroMide;Vortioxetine (Lu AA21004) HBr;Piperazine, 1-[2-[(2,4-dimethylphenyl)thio]phenyl]-, hydrobromide (1:1);1-[2-(2,4-Dimethyl-phenylsulfanyl)-phenyl]-piperazine, hydrobromid;Piperazine, 1-[2-[(2,4-dimethylphenyl)thio]phenyl]-, hydrobromide
Manufacturer | Product number | Product description | Packaging | Price | Updated | Buy |
---|
Properties
storage temp. :Refrigerator
solubility :DMSO (Slightly), Methanol (Slightly)
form :Solid
color :Pale Beige to Light Beige
InChI :InChI=1S/C18H22N2S.BrH/c1-14-7-8-17(15(2)13-14)21-18-6-4-3-5-16(18)20-11-9-19-10-12-20;/h3-8,13,19H,9-12H2,1-2H3;1H
InChIKey :VNGRUFUIHGGOOM-UHFFFAOYSA-N
SMILES :S(C1C=CC(C)=CC=1C)C1C=CC=CC=1N1CCNCC1.Br
Safety Information
Symbol(GHS): |
![]() ![]() |
||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Signal word: | Warning | ||||||||||||||||||||||||||||||
Hazard statements: |
|
||||||||||||||||||||||||||||||
Precautionary statements: |
|
Description
Vortioxetine (Brintellix) is an antidepressant that works through serotonin reuptake inhibition and direct receptor activity, acting as both a serotonin receptor agonist and antagonist.It is labeled for the treatment of major depressive disorder in adults.
Brintellix/Trintellix (vortioxetine) is approved for the treatment of major depressive disorder (MDD). Sales grew 10% (13% in local currencies) reaching DKK 3,102 million. The regional distribution of sales was 54%, 19% and 27% in North America, International Markets and Europe, respectively. The largest markets for the product are the U.S., Canada, Spain, Italy and Brazil. Brintellix/Trintellix has especially in the second half been impacted by the reduced promotional activity in many countries as a consequence of the COVID-19 pandemic thereby having impacted new patient enrolment negatively, particularly among primary care physicians (PCPs).
Related product price
- BENZTROPINE MESYLATE
₹4232.58-26300 - Dasatinib
₹3702.15-4546.5 - Bexarotene
₹9482.7-38417.93